Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Naloxone to Minimize Morphine Side-Effects in Anal Surgery
NCT03230474Completed
- Sponsor
- Assiut University
- Start
- May 2016
- Primary completion
- Feb 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial in postoperative nausea and vomiting (PONV), pruritus, postoperative urinary retention (POUR) and 1 more comparing Bupivacaine + Morphine + Placebo with Bupivacaine + Morphine + Naloxone (2 arms). Primary endpoint: Postoperative vomiting at 24 hours. Started May 2016; status: completed.
02
Drugs
naloxone
03
Conditions
postoperative nausea and vomiting (PONV)prurituspostoperative urinary retention (POUR)respiratory depression
Beyond the preview
Go deeper on NCT03230474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03230474.